Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Clene Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +2 vs. Q1 2025
- Shares held
- 582.1K
- +127.8K (+28.1%) vs. Q1 2025
- Total value
- $2.28M
- +$876.7K (+62.6%) vs. Q1 2025
- New holders
- 2
- 10 more added
- Sold out
- 0
- 4 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 188,357 | $736.5K | 0.00% | +55,023+41.3% | Added |
| Scoggin Management LP | 142,750 | $558.2K | 0.26% | +42,750+42.8% | Added |
| Geode Capital Management, LLC | 68,328 | $267.2K | 0.00% | −642−0.9% | Reduced |
| Lunt Capital Management, Inc. | 51,010 | $199.4K | 0.08% | +21,217+71.2% | Added |
| Parsons Capital Management Inc | 36,500 | $142.7K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 18,056 | $70.6K | 0.00% | +125+0.7% | Added |
| SBI Securities Co., Ltd. | 15,025 | $58.7K | 0.00% | +1,800+13.6% | Added |
| State Street Corp | 12,501 | $48.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,095 | $47.3K | 0.00% | +12,095 | New |
| Northern Trust Corp | 11,497 | $45.0K | 0.00% | 00.0% | Unchanged |
| Penn Davis McFarland Inc | 11,000 | $43.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,171 | $16.3K | 0.00% | 00.0% | Unchanged |
| Atlantic Private Wealth, LLC | 2,205 | $8.62K | 0.01% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,701 | $6.65K | 0.00% | −6,589−79.5% | Reduced |
| UBS Group AG | 1,678 | $6.56K | 0.00% | +1,368+441.3% | Added |
| Advisor Group Holdings, Inc. | 1,486 | $5.81K | 0.00% | +1,055+244.8% | Added |
| JPMorgan Chase & Co | 1,276 | $4.99K | 0.00% | +1,269+18,128.6% | Added |
| Tower Research Capital LLC (TRC) | 1,153 | $4.51K | 0.00% | −1,140−49.7% | Reduced |
| SRS Capital Advisors, Inc. | 1,070 | $4.18K | 0.00% | −612−36.4% | Reduced |
| MAI Capital Management | 100 | $391 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 64 | $250 | 0.00% | +13+25.5% | Added |
| Raymond James Financial Inc | 35 | $137 | 0.00% | +35 | New |
| BNP Paribas Arbitrage, SA | 23 | $90 | 0.00% | +10+76.9% | Added |
| US Bancorp | 20 | $78 | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |